The stock is down $1.21 to $38.61 in early trading.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Qualcomm downgraded, Rivian upgraded: Wall Street’s top analyst calls
- Novo Nordisk’s Hims deal helps with commercial headwind, says BMO Capital
- Novo Nordisk downgraded to Hold from Buy at TD Cowen
- Citi upgrades Hims & Hers to Neutral on Novo pact renewal
- Prothena achieves $50M clinical milestone payment from Novo Nordisk